Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  6. Summary
    603882   CNE100002VW1

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

(603882)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
98.6 102.84 98.09 98 97.45 Last
4393471 5120393 4912759 3358454 3560611 Volume
-4.84% +4.30% -4.62% -0.09% -0.56% Change
Estimated financial data (e)
Sales 2021 10 153 M 1 590 M 1 590 M
Net income 2021 1 833 M 287 M 287 M
Net cash position 2021 2 422 M 379 M 379 M
P/E ratio 2021 24,9x
Yield 2021 0,46%
Sales 2022 9 847 M 1 543 M 1 543 M
Net income 2022 1 536 M 241 M 241 M
Net cash position 2022 3 950 M 619 M 619 M
P/E ratio 2022 30,5x
Yield 2022 0,39%
Capitalization 45 081 M 7 061 M 7 062 M
EV / Sales 2021 4,20x
EV / Sales 2022 4,18x
Nbr of Employees 10 714
Free-Float 54,2%
More Financials
Company
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services. 
More about the company
Ratings of Guangzhou Kingmed Diagnostics Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
08/16Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Yea..
CI
06/24China stocks slip as healthcare firms retreat; Hong Kong up
RE
06/15GUANGZHOU KINGMED DIAGNOSTICS GROUP : 603882) added to Shanghai Stock Exchange 180 Value ..
CI
06/08Guangzhou Kingmed Diagnostics' Shareholder to Unload Up to 6% Stake
CI
04/19Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
03/25Guangzhou Kingmed Diagnostics Group Co., Ltd. announced that it has received CNY 149.99..
CI
02/10China's coronavirus anxiety super-charges testing business in holiday season
RE
2020Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Mon..
CI
2020GUANGZHOU KINGMED DIAGNOSTICS GROUP : 603882) added to FTSE All-World Index
CI
2020Certain A Shares of Guangzhou Kingmed Diagnostics Group Co., Ltd. are subject to a Lock..
CI
2020Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Yea..
CI
2020KingMed Diagnostics (Hong Kong) Limited announced that it expects to receive CNY 30 mil..
CI
2020Guangzhou Kingmed Diagnostics Group Co., Ltd. Announces Cash Dividend for the Year 2019..
CI
2020Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Yea..
CI
2020Guangzhou Kingmed Diagnostics Group Co., Ltd. announced that it expects to receive CNY ..
CI
More news
News in other languages on GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

- No features available -

More news
Stock Trading Strategies
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. - 2020
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Chart GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Duration : Period :
Guangzhou Kingmed Diagnostics Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 97,45 CNY
Average target price 191,23 CNY
Spread / Average Target 96,2%
EPS Revisions
Managers and Directors
Yao Ming Liang Chairman & General Manager
Bi Xi Hao CFO, Secretary, Director & Deputy General Manager
Yong Jian Chen Chairman-Supervisory Board
Shi Hui Yu Chief Scientist & Deputy General Manager
Jing Ming Xu Independent Director
Sector and Competitors